Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice

Abstract Background Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be associated with a high cumulative dose of DOX, the mechanisms of its l...

Descrición completa

Detalles Bibliográficos

Principais autores:	Takaaki Furihata, Satoshi Maekawa, Shingo Takada, Naoya Kakutani, Hideo Nambu, Ryosuke Shirakawa, Takashi Yokota, Shintaro Kinugawa
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2021-05-01
Series:	BMC Pharmacology and Toxicology
Assuntos:	Anticancer agent LV dysfunction Cardiac toxicity Thiazolidinediones
Acceso en liña:	https://doi.org/10.1186/s40360-021-00495-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!